Literature DB >> 17189390

Circulating methylated DNA: a new generation of tumor markers.

Martin Widschwendter1, Usha Menon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17189390     DOI： 10.1158/1078-0432.CCR-06-2531

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  13 in total

Review 1.  The multifaceted functional role of DNA methylation in immune-mediated rheumatic diseases.

Authors:  Matteo Vecellio; Haijing Wu; Qianjin Lu; Carlo Selmi
Journal:  Clin Rheumatol       Date:  2020-07-02       Impact factor: 2.980

Review 2.  Epigenomics and breast cancer.

Authors:  Pang-Kuo Lo; Saraswati Sukumar
Journal:  Pharmacogenomics       Date:  2008-12       Impact factor: 2.533

3.  Epigenetics and cancer, 2nd IARC meeting, Lyon, France, 6 and 7 December 2007.

Authors:  Marie-Pierre Lambert; Zdenko Herceg
Journal:  Mol Oncol       Date:  2008-03-27       Impact factor: 6.603

4.  Quantitative analysis and diagnostic significance of methylated SLC19A3 DNA in the plasma of breast and gastric cancer patients.

Authors:  Enders K O Ng; Candy P H Leung; Vivian Y Shin; Chris L P Wong; Edmond S K Ma; Hong Chuan Jin; Kent-Man Chu; Ava Kwong
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

5.  Global DNA hypomethylation in peripheral blood leukocytes as a biomarker for cancer risk: a meta-analysis.

Authors:  Hae Dong Woo; Jeongseon Kim
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

6.  GHSR DNA hypermethylation is a common epigenetic alteration of high diagnostic value in a broad spectrum of cancers.

Authors:  Evgeny A Moskalev; Pouria Jandaghi; Mahdi Fallah; Mehdi Manoochehri; Sandeep K Botla; Oleg V Kolychev; Evgeny A Nikitin; Vladymyr V Bubnov; M von Knebel Doeberitz; Oliver Strobel; Thilo Hackert; Markus W Büchler; Nathalia Giese; Andrea Bauer; Thomas Muley; Arne Warth; Peter Schirmacher; Florian Haller; Jörg D Hoheisel; Yasser Riazalhosseini
Journal:  Oncotarget       Date:  2015-02-28

Review 7.  Aberrant promoter CpG methylation and its translational applications in breast cancer.

Authors:  Ting-Xiu Xiang; Ying Yuan; Li-Li Li; Zhao-Hui Wang; Liang-Ying Dan; Yan Chen; Guo-Sheng Ren; Qian Tao
Journal:  Chin J Cancer       Date:  2011-11-04

Review 8.  DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update.

Authors:  Paul P Anglim; Todd A Alonzo; Ite A Laird-Offringa
Journal:  Mol Cancer       Date:  2008-10-23       Impact factor: 27.401

Review 9.  The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients.

Authors:  Yahya I Elshimali; Husseina Khaddour; Marianna Sarkissyan; Yanyuan Wu; Jaydutt V Vadgama
Journal:  Int J Mol Sci       Date:  2013-09-13       Impact factor: 5.923

10.  MethyQA: a pipeline for bisulfite-treated methylation sequencing quality assessment.

Authors:  Shuying Sun; Aaron Noviski; Xiaoqing Yu
Journal:  BMC Bioinformatics       Date:  2013-08-23       Impact factor: 3.169
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.